Enzo Biochem完成向Labcorp出售临床实验室后,股价上涨23%。来自ChatGPT翻译。查看全文
牛唐2021-03-21 15:41
$恩佐生化(ENZ)$ 在公布四季度财报后,CEO Dr. Rabbani提出辞呈,该行为受到大股东Harbert Discovery Fund的欢迎,但公司董事会未批准Dr. Rabbani的辞职。$钱江生化(SH600796)$ $绿康生化(SZ002868)$查看全文
美股短线交易员2020-03-12 11:03
$恩佐生化(ENZ)$ Trump speak on TV that " Testing is expanding rapidly day by day"查看全文
马虎公路2020-03-12 02:46
$风云际会(ZH2071612)$ @桂圆那个桂圆 调出$恩佐生化(ENZ)$ 之后,防疫类股票只剩一只$热生物制剂(HTBX)$ ,仓位8%,组合无法买卖,记录一下。防疫类的可能就做到这里了吧,后面先把精力放在指数正相关的版块上了。航空股,起飞吧查看全文
智通财经APP预告,2021年10月12日,港美股上市公司活动及香港重要财经会议信息情况如下: 20:30恩佐生化(ENZ.US) 恩佐生化(ENZ.US)2021年第四季度业绩电话会网络转播22:00快扣(FAST.US) 快扣(FAST.US)2021年第三季度业绩电话会网络转播2... 网页链接
智通财经APP预告,2021年3月16日,港美股上市公司活动及香港重要财经会议信息情况如下: 04:00 Startek, Inc.(SRT.US) Startek, Inc.(SRT.US)2020年第四季度业绩电话会 网络转播 04:30 恩佐生化(ENZ.US) 恩佐生化(ENZ.US)2020年第四季度... 网页链接
$恩佐生化(ENZ)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2015-12-28 AccNo: 0000930413-15-004860 Size: 25 KB 网页链接
$恩佐生化(ENZ)$ 8-K - Current report Filed: 2015-12-28 AccNo: 0000930413-15-004859 Size: 25 KBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$恩佐生化(ENZ)$ 8-K - Current report Filed: 2015-12-28 AccNo: 0000930413-15-004859 Size: 25 KBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$恩佐生化(ENZ)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2015-12-23 AccNo: 0000930413-15-004840 Size: 24 KB 网页链接
$恩佐生化(ENZ)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2015-12-23 AccNo: 0000930413-15-004830 Size: 73 KB 网页链接
$恩佐生化(ENZ)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2015-12-23 AccNo: 0000930413-15-004840 Size: 24 KB 网页链接
$恩佐生化(ENZ)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2015-12-23 AccNo: 0000930413-15-004830 Size: 73 KB 网页链接
$恩佐生化(ENZ)$ 8-K - Current report Filed: 2015-12-23 AccNo: 0000930413-15-004839 Size: 25 KBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$恩佐生化(ENZ)$ 8-K - Current report Filed: 2015-12-23 AccNo: 0000930413-15-004829 Size: 73 KBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$恩佐生化(ENZ)$ DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material Filed: 2015-12-22 AccNo: 0000921895-15-002843 Size: 175 KB 网页链接